---
figid: PMC7532472__ijmsv17p2454g007
figlink: pmc/articles/PMC7532472/figure/F7/
number: F7
caption: Schematic illustration of the results of the present study indicating that
  Dex preconditioning elevates cardiomyocytes mitochondrial coupling efficiency and
  membrane potential, which induces the inactivation of AMPK via α2-adrenergic receptor.
  Down-regulated AMPK further facilitates activation of ERK, AKT, PKC signaling and
  lead to cardiac hypertrophy, which protects heart against heart failure.
pmcid: PMC7532472
papertitle: 'An α2-adrenoceptor agonist: Dexmedetomidine induces protective cardiomyocyte
  hypertrophy through mitochondrial-AMPK pathway.'
reftext: Xiaojian Weng, et al. Int J Med Sci. 2020;17(16):2454-2467.
pmc_ranked_result_index: '65207'
pathway_score: 0.9451205
filename: ijmsv17p2454g007.jpg
figtitle: The results of the present study indicating that Dex preconditioning elevates
  cardiomyocytes mitochondrial coupling efficiency and membrane potential, which induces
  the inactivation of AMPK via A2-adrenergic receptor
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7532472__ijmsv17p2454g007.html
  '@type': Dataset
  description: Schematic illustration of the results of the present study indicating
    that Dex preconditioning elevates cardiomyocytes mitochondrial coupling efficiency
    and membrane potential, which induces the inactivation of AMPK via α2-adrenergic
    receptor. Down-regulated AMPK further facilitates activation of ERK, AKT, PKC
    signaling and lead to cardiac hypertrophy, which protects heart against heart
    failure.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - AKT2
  - AKT3
  - AKT1
  - dexmedetomidine
  - hypertrophy
genes:
- word: ΑMPK,
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: ΑMPK,
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: ΑMPK,
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: ΑMPK,
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: ΑMPK,
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: ΑMPK,
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: ΑMPK,
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: dexmedetomidine
  source: MESH
  identifier: D020927
diseases:
- word: hypertrophy
  source: MESH
  identifier: D006984
figid_alias: PMC7532472__F7
redirect_from: /figures/PMC7532472__F7
figtype: Figure
---
